Last reviewed · How we verify

SP Shz TIV — Competitive Intelligence Brief

SP Shz TIV (SP Shz TIV) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Inactivated influenza vaccine. Area: Immunology / Infectious Disease.

marketed Inactivated influenza vaccine Immunology / Infectious Disease Biologic Live · refreshed every 30 min

Target snapshot

SP Shz TIV (SP Shz TIV) — Sanofi. SP Shz TIV is a trivalent inactivated influenza vaccine that stimulates immune responses against three seasonal influenza virus strains.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
SP Shz TIV TARGET SP Shz TIV Sanofi marketed Inactivated influenza vaccine
inactivated split-virus influenza vaccine inactivated split-virus influenza vaccine The Cleveland Clinic marketed inactivated influenza vaccine
Anti-H1N1v Vaccine Anti-H1N1v Vaccine Institut National de la Santé Et de la Recherche Médicale, France marketed Inactivated influenza vaccine H1N1 influenza virus hemagglutinin and neuraminidase antigens
Prepandrix™ Prepandrix™ GlaxoSmithKline marketed Inactivated influenza vaccine H5N1 influenza virus surface antigens (hemagglutinin and neuraminidase)
Fluzone® (IM) Fluzone® (IM) National Institute of Allergy and Infectious Diseases (NIAID) marketed inactivated influenza vaccine
Hualan TIV Hualan TIV Sanofi marketed Inactivated influenza vaccine
adjuvanted Arepanrix adjuvanted Arepanrix University of British Columbia marketed Adjuvanted inactivated influenza vaccine H1N1 influenza virus hemagglutinin and neuraminidase antigens

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Inactivated influenza vaccine class)

  1. GlaxoSmithKline · 16 drugs in this class
  2. Seqirus · 5 drugs in this class
  3. Sanofi Pasteur, a Sanofi Company · 5 drugs in this class
  4. Green Cross Corporation · 4 drugs in this class
  5. Novartis · 2 drugs in this class
  6. SK Chemicals Co., Ltd. · 2 drugs in this class
  7. Sanofi · 2 drugs in this class
  8. Hospital Israelita Albert Einstein · 2 drugs in this class
  9. McGill University Health Centre/Research Institute of the McGill University Health Centre · 2 drugs in this class
  10. Il-Yang Pharm. Co., Ltd. · 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). SP Shz TIV — Competitive Intelligence Brief. https://druglandscape.com/ci/sp-shz-tiv. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: